New heart valve offers hope for High-Risk patients
NCT ID NCT04011722
First seen Jun 27, 2026 · Last updated Jul 22, 2026 · Updated 2 times
Summary
This study tests a next-generation heart valve (Navitor) in 333 people with severe aortic stenosis who are too high-risk for open-heart surgery. The goal is to see if the valve is safe and works well at 30 days, focusing on survival and reducing leaks around the valve. The valve is placed through a tube in the artery, avoiding major surgery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYMPTOMATIC SEVERE AORTIC STENOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Advocate Christ Medical Center
Oak Lawn, Illinois, 60453, United States
-
Albany Medical Center
Albany, New York, 12208, United States
-
Atlantic Health System - Morristown Memorial Hospital
Morristown, New Jersey, 07962, United States
-
Baptist Memorial Hospital
Memphis, Tennessee, 38120, United States
-
Cedars-Sinai Medical Center
Los Angeles, California, 90048, United States
-
Columbia University Medical Center/NYPH
New York, New York, 10032, United States
-
Fiona Stanley Hospital
Murdoch, Western Australia, 6150, Australia
-
Intermountain St. George Regional Hospital
St. George, Utah, 84790, United States
-
Los Robles Regional Medical Center
Thousand Oaks, California, 91360, United States
-
Minneapolis Heart Institute
Minneapolis, Minnesota, 55407, United States
-
Mission Health & Hospitals
Asheville, North Carolina, 28801, United States
-
Montefiore Medical Center - Moses Division
New York, New York, 10467, United States
-
Morriston Hospital - ABM University Health Board
Morriston, SWANSEA, SA6 6NL, United Kingdom
-
Policlinico San Donato
San Donato Milanese, Lombard, 20097, Italy
-
Providence St. Vincent Medical Center
Portland, Oregon, 97225, United States
-
Rigshospitalet
Copenhagen, 2100, Denmark
-
Royal Victoria Hospital
Belfast, Northern Ireland, BT12 6BA, United Kingdom
-
Sentara Norfolk General Hospital
Norfolk, Virginia, 23507, United States
-
Sparrow Clinical Research Institute
Lansing, Michigan, 48912, United States
-
St. Andrew's Hospital
Adelaide, South Australia, 5000, Australia
-
St. Vincent Hospital
Indianapolis, Indiana, 46240, United States
-
The Alfred Hospital
Melbourne, Victoria, 3004, Australia
-
The Heart Hospital Baylor Plano
Plano, Texas, 75093, United States
-
The Methodist Hospital
Houston, Texas, 77030, United States
-
University Hospitals Cleveland Medical Center
Cleveland, Ohio, 44106, United States
-
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, 15232, United States
-
Via Christi Regional Medical Center
Wichita, Kansas, 67214, United States
-
Washington Hospital Center
Washington D.C., District of Columbia, 20010, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Brain catcher: new device may prevent stroke during heart procedure
- Old gout drug may keep heart in rhythm after valve surgery
- New heart valve procedure shows promise for severe aortic stenosis
- New Balloon-Expandable heart valve tested in just 8 patients
- New heart valve study could offer seniors a Surgery-Free option
- New heart valve device tested in tiny early study